LY2033298

CAS No. 886047-13-8

LY2033298( —— )

Catalog No. M34325 CAS No. 886047-13-8

LY2033298, a positive allosteric modulator of muscarine M4 receptor, enhances the inhibitory effect of oximoline on light-induced phase shift in circadian activity in hamsters and can be used in neurosystem-related diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 135 In Stock
5MG 204 In Stock
10MG 351 In Stock
25MG 769 In Stock
50MG 1040 In Stock
100MG 1377 In Stock
500MG 2673 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LY2033298
  • Note
    Research use only, not for human use.
  • Brief Description
    LY2033298, a positive allosteric modulator of muscarine M4 receptor, enhances the inhibitory effect of oximoline on light-induced phase shift in circadian activity in hamsters and can be used in neurosystem-related diseases.
  • Description
    LY 2033298 is a selective positive allosteric modulator of the muscarinic M4 receptor. LY 2033298 can be used in the study of psychiatric disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    886047-13-8
  • Formula Weight
    311.79
  • Molecular Formula
    C13H14ClN3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1nc2sc(C(=O)NC3CC3)c(N)c2c(C)c1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chan WY, et al. Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10978-83.?
molnova catalog
related products
  • 9-Cyclopentyladenine

    9-Cyclopentyladenine (NSC-19486) is an adenylate cyclase inhibitor that blocks cellular morphological differentiation and phosphorylation of specific signaling molecules.

  • ±-Darifenacin

    (±)-Darifenacin ((±)-UK-88525) is a potential inhibitor of p53-MDM2 interaction with anticancer activity for the study of overactive bladder, Alzheimer's disease and Parkinson's disease.

  • Asoxime dichloride

    Asoxime dichloride (HI-6) is an antagonist to acetylcholine receptors (AChRs) including the nicotinic receptor, α7 nAChR.